Home
mdr-documentation-for-samd

MDR Documentation for SaMD

Medical Device Regulation (MDR) Documentation for Software as a Medical Device (SaMD)

The European Unions Medical Device Regulation (EU MDR 2017/745) has introduced significant changes to the regulation of medical devices, including software as a medical device (SaMD). SaMD refers to software that performs one or more medical functions and is intended to be used for diagnostic or therapeutic purposes. As with traditional medical devices, SaMD must meet the requirements set out in the EU MDR, including documentation.

What is MDR Documentation?

MDR documentation refers to the documents required by the European Unions Medical Device Regulation (EU MDR 2017/745) for the regulation of medical devices, including SaMD. The documentation must demonstrate that the device meets the requirements set out in the EU MDR and must be available for review by regulatory authorities upon request.

Key Components of MDR Documentation for SaMD

The following are key components of MDR documentation for SaMD:

  • Risk Management File (RMF): This document outlines the risks associated with the device and describes how they will be mitigated. The RMF should include an analysis of the potential harm caused by the device, as well as a description of the controls in place to minimize this harm.

  • Technical File: This document provides detailed information about the design, development, testing, and performance of the device. It must include:

  • A description of the softwares architecture and functionality

    Information about the development process, including design, coding, testing, and validation

    Details about the testing and validation of the software

    A summary of the results of any clinical trials or studies

  • Clinical Evaluation Report (CER): This document summarizes the clinical data used to demonstrate the safety and performance of the device. It should include an analysis of the relevant literature, as well as a description of any clinical trials or studies conducted.

  • Labeling and Instructions for Use: These documents provide information about how the software is intended to be used, including any specific instructions or warnings.


  • Detailed Explanation of Risk Management File (RMF) and Technical File

    Here are some detailed explanations of the RMF and Technical File in bullet point format:

    Risk Management File (RMF)

  • The risk management file should outline the risks associated with the device and describe how they will be mitigated.

  • This includes an analysis of the potential harm caused by the device, as well as a description of the controls in place to minimize this harm.

  • The RMF should also include:

  • A list of potential hazards associated with the device

    An analysis of the likelihood and severity of these hazards

    A description of the measures taken to mitigate these risks

    Information about any monitoring or surveillance activities that will be conducted to ensure ongoing safety

    Technical File

  • The technical file provides detailed information about the design, development, testing, and performance of the device.

  • This includes:

  • A description of the softwares architecture and functionality

    Information about the development process, including design, coding, testing, and validation

    Details about the testing and validation of the software
    Testing protocols
    Results of testing and validation
    Analysis of test data

    A summary of the results of any clinical trials or studies

    QA Section

    Here are some additional details about MDR documentation for SaMD:

    Q: What is the purpose of the Technical File?

    A: The Technical File provides detailed information about the design, development, testing, and performance of the device. This includes a description of the softwares architecture and functionality, as well as information about the development process, including design, coding, testing, and validation.

    Q: What is included in the Clinical Evaluation Report (CER)?

    A: The CER summarizes the clinical data used to demonstrate the safety and performance of the device. This includes an analysis of the relevant literature, as well as a description of any clinical trials or studies conducted.

    Q: How often must the Technical File be updated?

    A: The Technical File should be updated whenever changes are made to the software that affect its safety or performance. This includes updates to the design, development, testing, and validation processes.

    Q: Who is responsible for maintaining the Technical File?

    A: The manufacturer is responsible for maintaining the Technical File. This includes ensuring that it remains up-to-date and accurate, as well as making it available for review by regulatory authorities upon request.

    Q: What are the consequences of failing to maintain a compliant Technical File?

    A: Failure to maintain a compliant Technical File can result in regulatory action, including fines or even product recall. It is essential that manufacturers ensure that their Technical Files meet the requirements set out in the EU MDR and are available for review by regulatory authorities upon request.

    Q: How long must data be retained?

    A: Data should be retained for at least 10 years after the device has been placed on the market. This includes clinical trial data, testing results, and other relevant information that supports the safety and performance of the device.

    Q: Who can help with MDR documentation for SaMD?

    A: It is recommended to consult a regulatory expert or a medical writer who specializes in SaMD and has experience with EU MDR. They can provide guidance on compliance and ensure that the Technical File meets the requirements set out in the regulation.

    By following these guidelines and ensuring that your Technical File meets the requirements of the EU MDR, you can demonstrate compliance and avoid regulatory action. It is essential to stay up-to-date with the latest developments in SaMD regulation and to seek guidance from a regulatory expert if needed.

    DRIVING INNOVATION, DELIVERING EXCELLENCE